SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001654954-19-005929
Filing Date
2019-05-14
Accepted
2019-05-14 16:56:48
Documents
49
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A cvm_10q.htm 10-Q/A 32810
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF cvm_ex311.htm EX-31.1 29912
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE cvm_ex321.htm EX-32.1 6461
  Complete submission text file 0001654954-19-005929.txt   2687084

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cvm-20190331.xml EX-101.INS 718295
5 XBRL TAXONOMY EXTENSION SCHEMA cvm-20190331.xsd EX-101.SCH 42115
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20190331_cal.xml EX-101.CAL 39829
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20190331_def.xml EX-101.DEF 57551
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20190331_lab.xml EX-101.LAB 252211
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20190331_pre.xml EX-101.PRE 169212
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

IRS No.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 001-11889 | Film No.: 19823573
SIC: 2836 Biological Products, (No Diagnostic Substances)